Large-scale testing (Phase 3)Study completedNCT01811485
What this trial is testing
Study of Efficacy and Safety LMF237 in Patients With Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Vildagliptin Monotherapy
Who this might be right for
Diabetes Mellitus, Type 2
Novartis Pharmaceuticals 171